SCHEMBL21687609

SCHEMBL21687609

N#Cc1cc(-c2ccccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)ccc1-n1c2ccccc2c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.34
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TRPA1 O75762 1/20 0.34
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
IMPDH2 P12268 1/20 0.32
NR3C1 P04150 1/20 0.32
KDM4E B2RXH2 2/20 0.32
AR P10275 1/20 0.32
HTT P42858 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687896 0.92 PTGER4 (0.33) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21687984 0.92 CYP11B2 (0.34) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21687557 0.91 SMN1; SMN2 (0.35) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21687705 0.90 GABRA1 (0.32) ALDH1A1MEN1KMT2AALOX5APFEN1
SCHEMBL21687547 0.89 GABRA1 (0.32) ALDH1A1TDP1MEN1KMT2AALOX5AP
SCHEMBL21688244 0.89 GABRA1 (0.34) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21688042 0.88 ALDH1A1 (0.34) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21687647 0.87 SMN1; SMN2 (0.36) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21688040 0.86 ALDH1A1 (0.35) ALDH1A1TDP1MEN1TSHRKMT2A
SCHEMBL21688131 0.86 ALDH1A1 (0.35) ALDH1A1TDP1MEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885TDP1 3040/4885MEN1 669/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885TDP1 3040/4885MEN1 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.